Total Funding
35
57
Total FundingGrant raised
Growth Score 35 in past quarter
-5 pts
Heat Score 57 in past quarter
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
81474
Prapela is a noninvasive stimuation therapy that improves breathing and oxygenation in newborns.
- Jim Niemi: Co-founder & Technical Advisor
- David Morrill: VP of Product Development
About the Company
Prapela is an affordable, noninvasive stimulation therapy that improves newborn health. Our focus is on three clinical problems experienced by thousands of newborns every day. Placed inside a hospital bassinet or incubator, our reusable pad provides gentle stimulation that helps improve the natural processes of breathing control and oxygenation.
Since receiving our first award in 2017, Prapela has become America's most-awarded pediatric medical device startup. With over $8M in grants (and hopefully more), we are honored and motivated to work with neonatologists, the National Institutes of Health, and the FDA to improve the health of newborns.